Glenmark Pharmaceuticals Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Financial Year | Jun '26 | ||||
|---|---|---|---|---|---|
Total Qtr Revenue cr | 4,084.25 | ||||
| Other Income Qtr Cr | 65.76 | ||||
| Operating Revenues Qtr | 4,018.48 | ||||
Loading chart... | |||||
Operating Expenses Qtr | 3,213.69 | ||||
Operating Profit Qtr | 804.80 | ||||
EBITDA Qtr Cr | 870.56 | ||||
Depreciation Qtr | 173.17 | ||||
Net Profit Qtr | 482.92 | ||||
Basic EPS Qtr | 17.11 | ||||